Lactogenic hormone signal transduction

Biology of Reproduction

Volumn 58, Issue 2, 1998, Pages 295-301

  Yu Lee, Li Yuan ^a   Luo, Guoyang ^a   Book, Melissa L ^a   Morris, Shelli M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEFERON REGULATORY FACTOR 1; INTERFERON; PROLACTIN; PROLACTIN RECEPTOR; STAT1 PROTEIN; STAT5B PROTEIN; THROMBOCYTE ACTIVATING FACTOR; UNCLASSIFIED DRUG;

ASPERGILLUS NIDULANS; CONFERENCE PAPER; DNA BINDING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IMMUNE SYSTEM; PRIORITY JOURNAL; REGULATORY MECHANISM; SECOND MESSENGER; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; FEMALE; HUMANS; PREGNANCY; PROLACTIN; SIGNAL TRANSDUCTION;

ASPERGILLUS; EMERICELLA NIDULANS;

EID: 0031908083     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod58.2.295     Document Type: Conference Paper

References (59)

1. Yu-Lee L-y. Molecular actions of prolactin in the immune system. Proc Soc Exp Biol Med 1997; 215:35-52.
2. Nagy E, Berczi I, Friesen HG. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol 1983; 102:351-357.
3. Jara LJ, Gomez-Sanchez C, Silveira LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 1992; 303:222-226.
4. Nagy E, Berczi I, Wren GE, Asa SL, Kovacs K. Immunomodulation by bromocriptine. Immunopharmacology 1983; 6:231-243.
5. Bernton EW, Meltzer MS, Holaday JW. Suppression of macrophage activation and T-lymphocyte function in hypoprolactinemic mice. Science 1989; 239:401-404.
6. Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the Jak-STAT pathway. Annu Rev Biochem 1995; 64:621-651.
7. Gagnerault M-C, Touraine P, Savino W, Kelly PA, Dardenne M. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J Immunol 1993; 150:5673-5681.
8. O'Neal KD, Montgomery DW, Truong TM, Yu-Lee L-y. Prolactin gene expression in human thymocytes. Mol Cell Endocrinol 1992; 87: R19-R23.
9. Montgomery DW, Shen GK, Ulrich ED, Steiner LL, Parrish PR, Zukoski CF. Human thymocytes express a prolactin-like mRNA and synthesize bioactive prolactin-like proteins. Endocrinology 1992; 131: 3019-3026.
10. Ziemiecki A, Harpur AG, Wilks AF. JAK protein tyrosine kinases: their role in cytokine signalling. Trends Cell Biol 1994; 4:207-212.
11. Pawson T, Schlessinger J. SH2 and SH3 domains. Curr Biol 1993; 3: 434-442.
12. Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ. Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 1995; 270: 30264-30267.
13. Stocklin E, Wissler M, Gouilleux F, Groner B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature 1996; 383:726-728.
14. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell JE Jr. Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc Natl Acad Sci USA 1996; 93:15092-15096.
15. Horvai A, Xu L, Korzus E, Brard G, Kalafus D, Mullen T-M, Rose DW, Rosenfeld MG, Glass CK. Nuclear integration of Jak/Stat and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci USA 1997; 94:1074-1079.
16. Torchia J, Rose DW, Inostroza J, Kamei Y, Westin S, Glass CK, Rosenfeld MG. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature 1997; 387:677-684.
17. Gout PW, Beer CT, Noble RL. Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res 1980; 40:2433-2436.
18. Cox JH, Lamb JR, Bal V, Butcher GW, Howard JC, Owen MJ, Ivanyi J. The phenotypic and molecular characterization of Nb2 lymphoma cells activated with IL-2 and human growth hormone. Immunopharmacology 1989; 66:83-89.
19. Tanaka T, Shiu RPC, Gout PW, Beer CT, Noble RL, Friesen HG. A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol & Metab 1980; 51:1058-1063.
20. Yu-Lee L-y, Hrachovy JA, Stevens AM, Schwarz LA. Interferon-regulatory factor 1 is an immediate-early gene under transcriptional regulation by prolactin in Nb2 T cells. Mol Cell Biol 1990; 10:3087-3094.
21. Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 1988; 54:903-913.
22. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T. Anti-oncogenic and oncogenic potentials of interferon regulator factors-1 and -2. Science 1993; 259:971-974.
23. Abdollahi A, Lord KA, Hoffman-Liebermann B, Liebermann DA. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ 1991; 2:401-407.
24. Harroch S, Gothelf Y, Revel M, Chebath J. 5′ Upstream sequences of MyD88, an IL-6 primary response gene in M1 cells: detection of functional IRF-1 and Stat factors binding sites. Nucleic Acids Res 1995; 23:3539-3546.
25. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TW, Taniguchi T, Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994; 263:1612-1615.
26. Yamada G, Ogawa M, Akagi K, Miyamoto H, Nakano N, Itoh S, Miyazaki J-I, Nishikawa S-I, Yamamura K-I, Taniguchi T. Specific depletion of the B-cell population induced by aberrant expression of human interferon regulatory factor 1 gene in transgenic mice. Proc Natl Acad Sci USA 1991; 88:532-536.
27. Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S, Suzuki G, Mitsuyama M. Shin E-H, Kojima S, Taniguchi T, Asano Y. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 1997; 6:673-679.
28. Stevens AM, Wang Y-f, Sieger KA, Lu H-f, Yu-Lee L-y. Biphasic transcriptional regulation of the interferon regulatory factor-1 gene by prolactin: involvement of gamma-interferon activated sequence and Stat-related proteins. Mol Endocrinol 1995; 9:513-525.
29. Sims SH, Cha Y, Romine MF, Gao P-Q, Gottlieb K, Deisseroth AB. A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol Cell Biol 1993; 13:690-702.
30. Wang Y-f, O'Neal KD, Yu-Lee L-y. Multiple prolactin receptor cytoplasmic residues and Stat1 mediate prolactin signaling to the IRF-1 promoter. Mol Endocrinol 1997; 11:1353-1364.
31. Wang Y-f, Yu-Lee L-y. Multiple Stat complexes interact at the IRF-1 GAS in prolactin-stimulated Nb2 T cells. Mol Cell Endocrinol 1996; 121:19-28.
32. O'Neal KD, Yu-Lee L-y. The proline-rich motif (PRM): a novel feature of the cytokine/hematopoietin receptor superfamily. Lymph Cyt Res 1993; 12:309-312.
33. Lebrun J, Ali S, Sofer L, Ullrich A, Kelly PA. Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J Biol Chem 1994; 269:14021-14026.
34. Shikama N, Lyon J, La Thangue NB. The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol 1997; 7:230-236.
35. Luo G, Yu-Lee L-y. Transcriptional inhibition by Stat5: differential activities at growth-related versus differentiation-specific promoters. J Biol Chem 1997; (in press).
36. Ripperger JA, Fritz S, Richter K, Hocke GM, Lottspeich F, Fey GH. Transcription factors Stat3 and Stat5b are present in rat liver nuclei late in an acute phase response and bind interleukin-6 response elements. J Biol Chem 1995; 270:29998-30006.
37. Axtell SM, Truong TM, O'Neal KD, Yu-Lee L-y. Characterization of a prolactin-inducible gene, clone 15, in T cells. Mol Endocrinol 1995; 9:312-318.
38. Osmani AH, Osmani SA, Morris NR. The molecular cloning and identification of a gene product specifically required for nuclear movement in Aspergillus nidulans. J Cell Biol 1990; 111:543-551.
39. Morris NR, Enos AP. Mitotic gold in a mold: Aspergillus genetics and the biology of mitosis. Trends Genet 1992; 8:32-37.
40. Xiang X, Osmani AH, Osmani SA, Xin M, Morris NR. NudF, a nuclear migration gene in Aspergillus nidulans, is similar to the human LIS-1 gene required for neuronal migration. Mol Biol Cell 1995; 6: 297-310.
41. Reiner O, Albrecht U, Gordon M, Chianese KA, Wong C, Gal-Gerber O, Sapir T, Siracusa LD, Buchberg AM, Caskey CT, Eichele G. Lissencephaly gene (LIS1) expression in the CNS suggests a role in neuronal migration. J Neurosci 1995; 15:3730-3738.
42. Xiang X, Beckwith SM, Morris NR. Cytoplasmic dynein is involved in nuclear migration in Aspergillus nidulans. Proc Natl Acad Sci USA 1994; 91:2100-2104.
43. Xiang X, Roghi C, Morris NR. Characterization and localization of the cytoplasmic dynein heavy chain in Aspergillus nidulans. Proc Natl Acad Sci USA 1995; 92:9890-9894.
44. Willins DA, Xiang X, Morris NR. An alpha tubulin mutation suppresses nuclear migration mutations in Aspergillus nidulans. Genetics 1995; 141:1287-1298.
45. Morris SM, Anaya P, Xiang X, Morris NR, May GS, Yu-Lee L-y. A prolactin-inducible T cell gene product is structurally similar to the Aspergillus nidulans nuclear movement protein NUDC. Mol Endocrinol 1997; 11:229-236.
46. Morris SM, Yu-Lee L-y. Expression of RNUDC, a potential nuclear movement protein, in mammalian cells: localization to the Golgi apparatus. Exp Cell Res 1998; (in press).
47. Bloom GS, Brashear TA. A novel 58 kDa protein associates with the Golgi apparatus and microtubules. J Biol Chem 1989; 264:16083-16092.
48. Maclennan KM, Smith PF, Darlington CL. Platelet-activating factor in the CNS. Prog Neurobiol 1997; 50:585-596.
49. Frenkel RA, Muguruma K, Johnston JM. The biochemical role of platelet-activating factor in reproduction. Prog Lipid Res 1996; 35: 155-168.
50. Albrecht U, Abu-Issa R, Ratz B, Hattori M, Aoki J, Arai H, Inoue K, Eichele G. Platelet-activating factor acetylhydrolase expression and activity suggest a link between neuronal migration and platelet-activating factor. Dev Biol 1996; 180:579-593.
51. Kupfer A, Singer SJ. Cell biology of cytotoxic and helper T cell functions: immunofluorescence microscopic studies of single cells and cell couples. Annu Rev Immunol 1989; 7:309-337.
52. Tamura T, Ishihara M, Lamphier MS, Tanaka N, Oishi I, Aizawa S, Matusyama T, Mak TW, Taki S, Taniguchi T. An IRF-1-dependent pathway of DBA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 1995; 376:596-599.
53. Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M, Taniguchi T. Cooperation of the tumour suppressor IRF-1 and p53 in response to DNA damage. Nature 1996; 382:816-818.
54. Lohoff M, Ferrick D, Mottrucker H-W, Duncan GS, Bischof S, Rollinghoff M, Mak TW. Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 1997; 6:681-689.
55. Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Eagle SJ, Smith F, Markoff E, Dorshkind K. Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 1997: (in press).
56. Ormandy CJ, Camus AN, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes & Dev 1997; 11:167-178.
57. Luckow B, Schutz G. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res 1987; 15:5490.
58. Stevens AM, Yu-Lee L-y. Multiple prolactin-responsive elements mediate G1 and S phase expression of the interferon regulatory factor-1 gene. Mol Endocrinol 1994; 8:345-355.
59. Lebrun J, Suhad A, Goffin V, Ullrich A, Kelly PA. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc Natl Acad Sci USA 1995; 92:4031-4035.